Amphastar Pharmaceuticals, Inc. (AMPH) Financial Analysis and Rating

Comparison Analysis Based on SEC Data

Company Name Amphastar Pharmaceuticals, Inc.
Industry (SIC) 2834 - Pharmaceutical Preparations
Revenue in 2025 $719,887 thousand (ranked #118 out of 508 companies in the industry)
Assets as of 12/31/2025 $1,629 million (ranked #106)
Market Cap $989,220 thousand (Sep 4, 2026)
Analyzed report 12/31/2024 (filed 3/03/2025)

Year:
20242025

Financial Position and Performance
Annual | Quarterly

Compared with 2024 industry ratios Change during the year

better
unchanged
Compared with all listed companies

better

Compare with a competitor

Financial Ratios Benchmarking

Financial Ratio Comparison of company ratios for 2024
with industry ratios
(28 - Chemicals And Allied Products) 		with all listed companies
Solvency Ratios
Debt ratio 
0.54
0.48
0.54
0.61
Debt-to-equity ratio 
1.15
0.67
1.15
1.35
Interest coverage ratio 
7.25
-4.13
7.25
2.45
Liquidity Ratios
Current Ratio 
3.07
3.20
3.07
1.78
Quick Ratio 
2.06
1.84
2.06
1.06
Cash Ratio 
1.28
1.81
1.28
0.59
Profitability Ratios
Profit margin 
21.8%
-108.7%
21.8%
3%
ROE (Return on equity), after tax 
23.2%
-36.2%
23.2%
5.1%
ROA (Return on assets) 
10.3%
-25.1%
10.3%
0.9%
Activity Ratios
Asset turnover (days) 
773
1274
773
776
Receivables turnover (days) 
63
60
63
48
Resulting score +0,5 +1,0

Year:
20242025

Additional Ratios (not used in score calculation)

Financial Ratio Comparison of company ratios for 2024
with industry ratios
(28 - Chemicals And Allied Products) 		with all listed companies
Profitability Ratios
Gross margin 
51.1%
54.8%
51.1%
43.6%
Operating margin (Return on sales) 
30.1%
-21.6%
30.1%
5.1%
Activity Ratios
Inventory turnover (days) 
133
135
133
88
EBIT  $220M
EBITDA  $279M
Price Ratios
Earnings per Share (basic)  $3.29
Earnings per Share (diluted)